Yasuhisa Murai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Combination Therapy

Ulcerative Colitis

Brain Metastases

Top Venues

Diagnostics (Basel, Switzerland)

Molecular cancer therapeutics

EMBO molecular medicine

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher W Schultz, Yang Zhang, Rajaa El Meskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon A Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett A Schroeder, Manan Krishnamurthy, Laurel L Bassel, Rajesh Kumar, Nitin Roper, Mirit I Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. EMBO molecular medicine (2024)
Hiroto Hiraga, Daisuke Chinda, Keisuke Hasui, Yasuhisa Murai, Takato Maeda, Naoki Higuchi, Kohei Ogasawara, Sae Kudo, Yohei Sawada, Tetsuya Tatsuta, Hidezumi Kikuchi, Mami Ebina, Noriko Hiraga, Tatsuya Mikami, Hirotake Sakuraba, Shinsaku Fukuda
Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Hiroto Hiraga, Daisuke Chinda, Keisuke Hasui, Yasuhisa Murai, Takato Maeda, Naoki Higuchi, Kohei Ogasawara, Sae Kudo, Yohei Sawada, Tetsuya Tatsuta, Hidezumi Kikuchi, Mami Ebina, Noriko Hiraga, Tatsuya Mikami, Hirotake Sakuraba, Shinsaku Fukuda
Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Junko Murai, Michele Ceribelli, Haiqing Fu, Christophe E Redon, Ukhyun Jo, Yasuhisa Murai, Mirit I Aladjem, Craig J Thomas, Yves Pommier
Schlafen 11 (SLFN11) kills cancer cells undergoing unscheduled re-replication. Molecular cancer therapeutics (2023)
Hiroto Hiraga, Daisuke Chinda, Takato Maeda, Yasuhisa Murai, Kohei Ogasawara, Ryutaro Muramoto, Shinji Ota, Keisuke Hasui, Hirotake Sakuraba, Yoh Ishiguro, Shukuko Yoshida, Krisana Asano, Akio Nakane, Shinsaku Fukuda
Vitamin A Promotes the Fusion of Autophagolysosomes and Prevents Excessive Inflammasome Activation in Dextran Sulfate Sodium-Induced Colitis. International journal of molecular sciences 24 (10) (2023)
Kohei Ogasawara, Hiroto Hiraga, Yoshihiro Sasaki, Noriko Hiraga, Naoki Higuchi, Keisuke Hasui, Shinji Ota, Takato Maeda, Yasuhisa Murai, Tetsuya Tatsuta, Hidezumi Kikuchi, Daisuke Chinda, Tatsuya Mikami, Masashi Matsuzaka, Hirotake Sakuraba, Shinsaku Fukuda
A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn's Disease Using a Brute Force Method. Diagnostics (Basel, Switzerland) 13 (23) (2023)
Christopher W Schultz, Yang Zhang, Rajaa El Meskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon A Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett A Schroeder, Manan Krishnamurthy, Rajesh Kumar, Nitin Roper, Mirit I Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. EMBO molecular medicine (2023)
Hiroto Hiraga, Daisuke Chinda, Keisuke Hasui, Yasuhisa Murai, Takato Maeda, Naoki Higuchi, Kohei Ogasawara, Sae Kudo, Yohei Sawada, Tetsuya Tatsuta, Hidezumi Kikuchi, Mami Ebina, Noriko Hiraga, Tatsuya Mikami, Hirotake Sakuraba, Shinsaku Fukuda
Evaluation of Crohn's Disease Small-Bowel Mucosal Healing Using Capsule Endoscopy and Usefulness of Leucine-Rich α2-Glycoprotein. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Naoki Higuchi, Hiroto Hiraga, Yoshihiro Sasaki, Noriko Hiraga, Shohei Igarashi, Keisuke Hasui, Kohei Ogasawara, Takato Maeda, Yasuhisa Murai, Tetsuya Tatsuta, Hidezumi Kikuchi, Daisuke Chinda, Tatsuya Mikami, Masashi Matsuzaka, Hirotake Sakuraba, Shinsaku Fukuda
Automated evaluation of colon capsule endoscopic severity of ulcerative colitis using ResNet50. PloS one 17 (6) (2022)
Ukhyun Jo, Yasuhisa Murai, Keli K Agama, Yilun Sun, Liton Kumar Saha, Xi Yang, Yasuhiro Arakawa, Sophia Gayle, Kelli Jones, Vishwas Paralkar, Ranjini K Sundaram, Jinny Van Doorn, Juan C Vasquez, Ranjit S Bindra, Woo Suk Choi, Yves Pommier
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular cancer therapeutics 21 (7) (2022)
Hidezumi Kikuchi, Hirotake Sakuraba, Yui Akemoto, Kazuhiro Hosoi, Yasuhisa Murai, Kentaro Hoshi, Yukari Fukutoku, Taka Asari, Yohei Sawada, Keisuke Hasui, Tetsuya Tatsuta, Hiroto Hiraga, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
Endoscopic and histopathologic features of Anti-PD-1-related collagenous colitis. DEN open 2 (1) (2022)
Ukhyun Jo, Yasuhisa Murai, Naoko Takebe, Anish Thomas, Yves Pommier
Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11. Cancers 13 (18) (2021)
Ukhyun Jo, Yasuhisa Murai, Sirisha Chakka, Lu Chen, Ken Cheng, Junko Murai, Liton Kumar Saha, Lisa M Miller Jenkins, Yves Pommier
SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors. Proceedings of the National Academy of Sciences of the United States of America 118 (6) (2021)
Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W Schultz, Anish Thomas, Frank T Zenke, Yves Pommier
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents. Molecular cancer therapeutics 20 (8) (2021)
Yasuhisa Murai, Ukhyun Jo, Junko Murai, Lisa M Miller Jenkins, Shar-Yin N Huang, Sirisha Chakka, Lu Chen, Ken Cheng, Shinsaku Fukuda, Naoko Takebe, Yves Pommier
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243. Cancer research 81 (11) (2021)